{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":21,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":21,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"b2d2ae028a2a","filters":{"venue":"Vivli"}},"results":[{"id":"W6889596690","doi":"10.25934/pr00009377","title":"Biomarker discovery for immunotherapy response via pan-cancer and cancer-specific analyses","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Biomarker discovery; Immunotherapy; Informatics; Immune checkpoint; Cancer; Clinical trial; Biomarker; Cancer immunotherapy; Cancer biomarkers","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.06698971287844391,"gpt":0.4013903195204984,"spread":0.3344006066420545,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02062238,0.001509385,0.003464602,0.007920421,0.0005843103,0.003301024,0.001104455,0.001125434,0.003096332],"category_scores_gemma":[0.03032215,0.0004883521,0.006205284,0.01088953,0.0006134365,0.001914448,0.001741008,0.001586368,0.0005441082],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008562498,"about_ca_system_score_gemma":0.001447926,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001736199,"about_ca_topic_score_gemma":0.002367579,"domain_scores_codex":[0.9910679,0.004557067,0.001025566,0.002238532,0.0007799724,0.0003308922],"domain_scores_gemma":[0.9817836,0.01066809,0.00346961,0.002239207,0.001455485,0.000384103],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003492196,0.000287219,0.7106189,0.004918857,0.0538708,0.0005126145,0.0002964596,0.0208112,0.008319939,0.00446855,0.008999355,0.1834039],"study_design_scores_gemma":[0.0008330808,0.00309792,0.5406838,0.001612177,0.1028238,0.002411792,0.0008903921,0.1482108,0.01704478,0.09497688,0.08694673,0.000467972],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.4627023,0.1482816,0.3163181,0.009290704,0.001467761,0.001297259,0.0494343,0.002768431,0.008439616],"genre_scores_gemma":[0.9191117,0.006861488,0.05688406,0.001736658,0.0006414294,0.0006978565,0.01269895,0.0002538441,0.001113971],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.02062238,"threshold_uncertainty_score":0.1090629,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6908286552","doi":"10.25934/pr00010843","title":"Efficacy of Glucose-Lowering Drugs for Young-Onset Type 2 Diabetes: A Meta-Analysis of Individual Participant Data from Randomized Control Trials","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University Health Network","funders":"","keywords":"Type 2 diabetes; Diabetes mellitus; Blood sugar; Drug; Randomized controlled trial; Clinical trial; MEDLINE","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2375551830621531,"gpt":0.4037007682444479,"spread":0.1661455851822947,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03556096,0.002946998,0.01644038,0.003894195,0.0005249875,0.003204984,0.002260282,0.00231725,0.003376139],"category_scores_gemma":[0.05650723,0.001609261,0.05992337,0.004992509,0.0006215489,0.002048697,0.001575979,0.003536968,0.0003375333],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001564391,"about_ca_system_score_gemma":0.00160716,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005472403,"about_ca_topic_score_gemma":0.007569951,"domain_scores_codex":[0.9682841,0.02124404,0.005310258,0.00266448,0.001818309,0.0006788375],"domain_scores_gemma":[0.9524626,0.03723985,0.005063437,0.002813247,0.001834385,0.0005865251],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.008066012,0.00002767342,0.005617933,0.02321276,0.958187,0.00006293754,0.00003028238,0.000656915,0.0001123596,0.00009027966,0.0005083774,0.003427453],"study_design_scores_gemma":[0.00287229,0.0002520541,0.005354218,0.001590663,0.9881971,0.00004809212,0.00002332967,0.0004685022,0.00009405112,0.0003016733,0.0007737363,0.00002421575],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"dataset","genre_scores_codex":[0.06557097,0.9172874,0.006962277,0.001083968,0.001419344,0.0009660744,0.005158277,0.0002675122,0.001284138],"genre_scores_gemma":[0.8131854,0.1647667,0.009177665,0.002434714,0.0006685875,0.002785785,0.005843373,0.0002230648,0.0009146929],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.03556096,"threshold_uncertainty_score":0.1880666,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6889640636","doi":"10.25934/00005663","title":"A Phase II/III, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Multicenter Study to Evaluate the Safety and Efficacy of Rituximab in Adults With Primary Progressive Multiple Sclerosis","year":2020,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Multicenter study; Rituximab; Placebo; Multiple sclerosis; Phases of clinical research; Multicenter trial","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03169117088397654,"gpt":0.3043936615560763,"spread":0.2727024906720998,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00546125,0.001721539,0.002686158,0.0005943094,0.0007161795,0.001114514,0.002548116,0.001612923,0.0228421],"category_scores_gemma":[0.007492312,0.0006312029,0.001496661,0.001103058,0.0003909358,0.0006982699,0.0007442669,0.00164325,0.004743567],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001718311,"about_ca_system_score_gemma":0.004749381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01129314,"about_ca_topic_score_gemma":0.02901117,"domain_scores_codex":[0.998413,0.000904535,0.0001253162,0.00018389,0.0002506441,0.0001225965],"domain_scores_gemma":[0.996794,0.0007814682,0.0008867059,0.0004036337,0.0006034619,0.0005307159],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3917539,0.004375425,0.01184164,0.007691632,0.005431187,0.0001662013,0.00009244551,0.001211282,0.001922481,0.001402471,0.5239861,0.05012526],"study_design_scores_gemma":[0.8139483,0.008181355,0.03540115,0.001121863,0.004107154,0.0002887153,0.00006302438,0.00180629,0.0008554466,0.001523237,0.1325961,0.0001073221],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.02899378,0.00358762,0.002338178,0.00240045,0.0004377707,0.01469352,0.9379404,0.000595773,0.009012521],"genre_scores_gemma":[0.0660674,0.003524088,0.01163033,0.003921206,0.0002805133,0.04409682,0.8593772,0.0002127214,0.01088959],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.0228421,"threshold_uncertainty_score":0.07641447,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6964545150","doi":"10.25934/pr00009081","title":"Antidepressant effects of bupropion, varenicline, nicotine replacement therapy, and placebo in tobacco users.","year":2023,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"McGill University","funders":"","keywords":"Varenicline; Nicotine; Craving; Antidepressant; Placebo; Smoking cessation; Bupropion; Mood; Nicotine replacement therapy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01985587081442298,"gpt":0.2815772220963098,"spread":0.2617213512818868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001071234,0.0004596769,0.001643874,0.0004887638,0.0002384851,0.0004044672,0.0004510704,0.000848861,0.005125927],"category_scores_gemma":[0.00154455,0.0004278259,0.001094754,0.0003667671,0.0003397467,0.0006306004,0.0002899106,0.001292502,0.0005682906],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003132187,"about_ca_system_score_gemma":0.000351666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007341117,"about_ca_topic_score_gemma":0.001894631,"domain_scores_codex":[0.9993078,0.0003527839,0.0001038131,0.00007170515,0.00008597162,0.00007795369],"domain_scores_gemma":[0.999459,0.0001751886,0.0001370091,0.00003845805,0.0000512517,0.0001390857],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.7391636,0.01845251,0.001868833,0.002570283,0.002274698,0.0001880418,0.0002738028,0.0002899839,0.02832835,0.0003124705,0.001981109,0.2042963],"study_design_scores_gemma":[0.3483039,0.5986893,0.03437033,0.0003188268,0.00273288,0.0004971928,0.0002423844,0.001358731,0.006894134,0.0003352996,0.006192228,0.00006491054],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.955081,0.03764021,0.0002599042,0.000644828,0.0006285693,0.0008659592,0.0009168474,0.00009047474,0.003872174],"genre_scores_gemma":[0.9771801,0.01582347,0.0009484335,0.0005790684,0.0004089125,0.0007762478,0.0007736494,0.00001133044,0.003498845],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.005125927,"threshold_uncertainty_score":0.01714796,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7081132269","doi":"10.25934/pr00008913","title":"T1-DEXi-T Study: Does exercise training improve the time in range following acute bouts of exercise?","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"Geochemistry and Geologic Mapping","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"McMaster University","funders":"","keywords":"Exercise prescription; Wearable computer; Type 2 diabetes; Intervention (counseling); Cardiovascular health; Activities of daily living; Diabetes mellitus; Training (meteorology)","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0102877532176407,"gpt":0.2490431271474704,"spread":0.2387553739298297,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007544691,0.0008672738,0.001743083,0.0004902219,0.0009769124,0.00225603,0.001458066,0.002445581,0.009728325],"category_scores_gemma":[0.0140882,0.000398973,0.003842969,0.001015708,0.0006284047,0.001985299,0.001542939,0.003140584,0.003717282],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006468093,"about_ca_system_score_gemma":0.00163748,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002672495,"about_ca_topic_score_gemma":0.00462288,"domain_scores_codex":[0.9975647,0.001174835,0.0002598876,0.0004795633,0.0002797461,0.0002414621],"domain_scores_gemma":[0.9919686,0.002934478,0.001249144,0.001319573,0.001270769,0.001257519],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.2552001,0.01829152,0.2491309,0.01917603,0.01741177,0.0005320407,0.001656643,0.001216743,0.005968721,0.005806264,0.1035797,0.3220296],"study_design_scores_gemma":[0.05467762,0.08057808,0.6392187,0.006992474,0.0232633,0.0008337102,0.001568359,0.001861585,0.004797195,0.008808843,0.1768192,0.0005809292],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.6980781,0.06608184,0.01819223,0.03561947,0.01107841,0.01835929,0.08788949,0.0006638166,0.06403744],"genre_scores_gemma":[0.7819764,0.02182945,0.02576015,0.03136918,0.01012311,0.03743184,0.06809059,0.0006225858,0.02279681],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.009728325,"threshold_uncertainty_score":0.03990066,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6946233082","doi":"10.25934/pr00010916","title":"Predictability of biomarkers and disease activity indices for efficacy of advanced therapies in Crohn’s disease","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University","funders":"","keywords":"Disease; Ulcerative colitis; Inflammatory bowel disease; Abdominal pain; Clinical disease; Inflammation; Biomarker; Predictability","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01182966804595067,"gpt":0.3044365102672706,"spread":0.2926068422213199,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004702662,0.001018937,0.00211613,0.001824612,0.0002781786,0.001760187,0.0004048044,0.0009596171,0.001884793],"category_scores_gemma":[0.01891793,0.0003340658,0.001833617,0.002192766,0.0003739325,0.001126238,0.0006986953,0.002199407,0.000748865],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00041555,"about_ca_system_score_gemma":0.000461851,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009128459,"about_ca_topic_score_gemma":0.0009759932,"domain_scores_codex":[0.9974251,0.001017565,0.0004725476,0.000424329,0.0004808046,0.0001797247],"domain_scores_gemma":[0.9837875,0.009214778,0.004384577,0.000712781,0.001185743,0.0007144262],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002308578,0.0002096315,0.9577085,0.0003987003,0.00111609,0.0001101584,0.00009113094,0.003677854,0.0005535856,0.0003134003,0.001755054,0.03175729],"study_design_scores_gemma":[0.0002003355,0.001958961,0.9534801,0.0004364931,0.001626801,0.0004793024,0.000218459,0.03176657,0.001198986,0.002593914,0.005945543,0.00009466013],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9207692,0.05538524,0.009155359,0.001769335,0.0007248272,0.0002607491,0.006257794,0.0002219764,0.005455501],"genre_scores_gemma":[0.9911023,0.002550577,0.002885642,0.0002070277,0.0002905515,0.00008542548,0.002521615,0.00001705303,0.000339708],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.004702662,"threshold_uncertainty_score":0.02487034,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6945990900","doi":"10.25934/00003792","title":"Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis","year":2019,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Atopic dermatitis; Randomized controlled trial; Multicenter study; Atopy; Clinical trial; Clinical study","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.06535152408763242,"gpt":0.344640428952276,"spread":0.2792889048646435,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00327635,0.001810666,0.003815431,0.0006674398,0.0008794059,0.0008131128,0.00122817,0.003241517,0.008557517],"category_scores_gemma":[0.002362333,0.000857024,0.001342006,0.0004631158,0.0008451903,0.0009594549,0.0004289306,0.003209138,0.002606452],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000684263,"about_ca_system_score_gemma":0.003347745,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008871513,"about_ca_topic_score_gemma":0.002609451,"domain_scores_codex":[0.9980129,0.001241311,0.0001656422,0.0001639491,0.0002391374,0.0001771183],"domain_scores_gemma":[0.9983418,0.0004978349,0.0003042678,0.0001429234,0.0001899752,0.0005231355],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8182383,0.09887915,0.001342515,0.002034017,0.0005721849,0.0002233708,0.0001289326,0.0004079809,0.02885515,0.0003964913,0.005721505,0.04320055],"study_design_scores_gemma":[0.6254557,0.3689485,0.001750582,0.00003884908,0.0001467029,0.00009018146,0.00001977485,0.0002711516,0.001614706,0.0000701358,0.00156714,0.0000266974],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9248779,0.004039902,0.002545052,0.001344303,0.000883367,0.05146921,0.004874042,0.0005190868,0.009447194],"genre_scores_gemma":[0.8913898,0.005430809,0.01061703,0.006237945,0.001604097,0.06622147,0.005250079,0.0001240838,0.0131245],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.008557517,"threshold_uncertainty_score":0.02862781,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6908450664","doi":"10.25934/pr00004920","title":"Predicting Treatment Efficacy in Individuals with Major Depression -- Deep Neural Networks for Physiological Patient Parameters","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Douglas Mental Health University Institute","funders":"","keywords":"Depression (economics); Mental illness; Neurostimulation; Mental health; Clinical trial","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02326669706524894,"gpt":0.283555226787726,"spread":0.2602885297224771,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001195136,0.000600421,0.0008004191,0.0007747839,0.000188443,0.0009198823,0.0004534575,0.0009255458,0.002063871],"category_scores_gemma":[0.005946795,0.000215484,0.0007154595,0.0004459773,0.0001665062,0.0005507242,0.0004525703,0.001332926,0.000521308],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006676109,"about_ca_system_score_gemma":0.0004660038,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004630311,"about_ca_topic_score_gemma":0.007084769,"domain_scores_codex":[0.9996148,0.0001252003,0.00004967393,0.00009152025,0.00006053125,0.00005818153],"domain_scores_gemma":[0.9988909,0.0006985625,0.0001681371,0.00004569201,0.0001129465,0.00008369191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003552336,0.00194494,0.487262,0.0006719434,0.001374671,0.0004570163,0.0002108685,0.09225959,0.003043617,0.001472471,0.0258513,0.3818994],"study_design_scores_gemma":[0.0002498514,0.001027306,0.1582864,0.0003923827,0.000521049,0.0003597847,0.0002370159,0.8264095,0.001777384,0.007519891,0.003155726,0.00006372132],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9056275,0.01024618,0.05300119,0.008124946,0.0005035739,0.0004086666,0.01443341,0.000663344,0.006991365],"genre_scores_gemma":[0.9865124,0.001031803,0.007324763,0.0006388811,0.0001692799,0.0001630693,0.003268061,0.00002304114,0.0008687138],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.004630311,"threshold_uncertainty_score":0.009206712,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6889692353","doi":"10.25934/pr00009332","title":"Outcomes from Induction Using Ustekinumab or Vedolizumab Among Patients Who Have Prior Biologic Intolerance vs Biologic Failure in Ulcerative colitis and Crohn's disease","year":2024,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Ulcerative colitis; Ustekinumab; Vedolizumab; Inflammatory bowel disease; Disease; Abdominal pain; Crohn's disease","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.03290112867001576,"gpt":0.2922660289213194,"spread":0.2593649002513037,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009753364,0.0002218348,0.0009932393,0.000405906,0.0004125188,0.0008892438,0.000354976,0.0006626021,0.002166325],"category_scores_gemma":[0.002423308,0.000144938,0.002351052,0.0006990613,0.0003082737,0.000712478,0.0007012101,0.001768962,0.0002520398],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006527913,"about_ca_system_score_gemma":0.0005005858,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001173795,"about_ca_topic_score_gemma":0.001836961,"domain_scores_codex":[0.9993262,0.0001768388,0.00009238606,0.0001072872,0.0001075713,0.0001896375],"domain_scores_gemma":[0.9975114,0.0004448793,0.001114019,0.00006569603,0.0001175586,0.0007464184],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0687608,0.001717892,0.8412447,0.001247123,0.002280169,0.0005112091,0.0003820431,0.0008042679,0.00118203,0.0004348475,0.00345419,0.07798067],"study_design_scores_gemma":[0.003672435,0.01487565,0.9721134,0.000692313,0.002416328,0.000769127,0.0005274258,0.0009828048,0.0003276186,0.0004756723,0.003092714,0.00005445204],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9847974,0.0121134,0.00008621651,0.0005137311,0.0001317658,0.00005639929,0.0006312992,0.000006699456,0.001663067],"genre_scores_gemma":[0.9957646,0.002034232,0.00006569523,0.0004208137,0.0001551513,0.00005597357,0.001157536,0.000002794568,0.0003431983],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.002166325,"threshold_uncertainty_score":0.00724709,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6908434345","doi":"10.25934/pr00006175.0","title":"Available IPD datapackage for study 'A Bioequivalence Study of the Fixed Dose Combination Dapagliflozin/Metformin Tablet (5 mg/850 mg) Relative to a 5 mg Dapagliflozin Tablet and an 850 mg Metformin (Glucophage® Marketed in Canada by Sanofi-Aventis) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed States'","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bioequivalence; Metformin; Dapagliflozin; Fixed-dose combination; Glimepiride; Pharmacokinetics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02844765649905483,"gpt":0.322918681402331,"spread":0.2944710249032762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002917022,0.002484341,0.002138254,0.002246837,0.000602798,0.001918293,0.003252646,0.003547498,0.07834838],"category_scores_gemma":[0.01328602,0.0007868148,0.002383066,0.00414658,0.000518771,0.001034074,0.001599799,0.001829239,0.06304619],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00150806,"about_ca_system_score_gemma":0.003298068,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02189339,"about_ca_topic_score_gemma":0.03436789,"domain_scores_codex":[0.9981942,0.0004616449,0.0002875123,0.0004536746,0.0004246657,0.000178392],"domain_scores_gemma":[0.9949368,0.002164539,0.0008109559,0.0009330655,0.0008673391,0.0002873097],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005345712,0.00008362721,0.001788503,0.003095754,0.0002537676,0.00003879269,0.00002237503,0.001008302,0.0002095712,0.0005372728,0.9882917,0.004135755],"study_design_scores_gemma":[0.004120582,0.0001817359,0.00886397,0.001178153,0.0004164175,0.0001262406,0.00004833226,0.001858869,0.0006208972,0.002300447,0.9802085,0.00007573422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.0001282253,0.0001206354,0.00007218468,0.00005480053,0.00001753522,0.00002268234,0.9991315,0.0001445891,0.0003078718],"genre_scores_gemma":[0.0006117472,0.0000860123,0.0003170059,0.00008161325,0.00000901779,0.0001703716,0.9982192,0.00004647349,0.0004584996],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.9781066,"threshold_uncertainty_score":0.2621014,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6964497678","doi":"10.25934/pr00010997","title":"Re-analyzing Heart Failure Treatment Outcomes Based on Patient Preferences: A Study Using Data from Multiple Clinical Trials","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Clinical trial; Quality of life (healthcare); Heart failure; Quality (philosophy); Event (particle physics); Balance (ability)","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.5015705775995087,"gpt":0.5093918840397282,"spread":0.0078213064402195,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2692159,0.003856047,0.01209413,0.006251921,0.00164488,0.007200339,0.004376627,0.004395263,0.006793876],"category_scores_gemma":[0.4565153,0.001479806,0.03684867,0.01221579,0.002305951,0.009385929,0.003853992,0.005587818,0.001162332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00225897,"about_ca_system_score_gemma":0.001982572,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001313222,"about_ca_topic_score_gemma":0.002037911,"domain_scores_codex":[0.5699285,0.3248489,0.05583251,0.02243655,0.02447296,0.002480736],"domain_scores_gemma":[0.3395072,0.4844336,0.09575589,0.06134458,0.01602789,0.002930809],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"observational","study_design_scores_codex":[0.0511788,0.001759908,0.2662802,0.02567535,0.5570827,0.0008337393,0.001280867,0.006233979,0.001267422,0.002649037,0.005685058,0.08007301],"study_design_scores_gemma":[0.03952378,0.0241531,0.2753399,0.009078387,0.5501421,0.003191147,0.00176279,0.0390859,0.002929657,0.01602681,0.03735346,0.001412885],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.6261292,0.1833756,0.1184578,0.009066148,0.00545561,0.0173701,0.0296813,0.000733518,0.009730741],"genre_scores_gemma":[0.9000953,0.006807662,0.05807808,0.005393838,0.001349558,0.01541281,0.01131331,0.0002948457,0.001254627],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.2692159,"threshold_uncertainty_score":0.9011869,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6964672847","doi":"10.25934/00000684","title":"An Open-label, Randomized, Single Dose, Two-period Crossover Study to Demonstrate Bioequivalence Between the Controlled Release Paroxetine Tablet (37.5 mg) Manufactured at Cidra and Mississauga","year":2018,"lang":"en","type":"dataset","venue":"Vivli","topic":"Forest Ecology and Biodiversity Studies","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Bioequivalence; Paroxetine; Immediate release; Crossover study; Controlled release; Dosage form","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04077867042252856,"gpt":0.2877597463769197,"spread":0.2469810759543911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004454588,0.0009596467,0.001966128,0.0004217329,0.0005863229,0.0008601,0.001896395,0.001566787,0.022791],"category_scores_gemma":[0.01037309,0.0003730477,0.001419404,0.0009060533,0.0004100099,0.0006040426,0.0007619017,0.001484492,0.006403578],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001236565,"about_ca_system_score_gemma":0.002679789,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006379216,"about_ca_topic_score_gemma":0.01358779,"domain_scores_codex":[0.9984302,0.000766921,0.0002084063,0.0002603618,0.000224264,0.0001098457],"domain_scores_gemma":[0.9951214,0.001369764,0.001230786,0.0009532228,0.0009319756,0.000392909],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.24948,0.006045513,0.03514386,0.01289528,0.005826274,0.0002749772,0.0002136607,0.00116202,0.002421204,0.001620164,0.6332835,0.05163356],"study_design_scores_gemma":[0.4125565,0.01271481,0.1850489,0.002877371,0.007555118,0.0006284504,0.0002583595,0.00344056,0.002325856,0.002443629,0.3699571,0.000193382],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.06130706,0.002164426,0.001870715,0.001093839,0.0002630019,0.009495455,0.9162585,0.0004666008,0.007080424],"genre_scores_gemma":[0.1311811,0.001361003,0.008480738,0.001755037,0.0001843575,0.03715403,0.8097296,0.0001800958,0.009974115],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.022791,"threshold_uncertainty_score":0.07624346,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6889769029","doi":"10.25934/pr00007817","title":"Predictors of Histologic Response using Antibodies Against Interleukin-5 in Eosinophilic Esophagitis","year":2023,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Eosinophilic esophagitis; Mepolizumab; Immune system; Eosinophilia; Histology; Eosinophilic gastroenteritis; Eosinophil; Immunopathology; Eosinophilic","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04076643830718461,"gpt":0.3077268666848046,"spread":0.26696042837762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006402993,0.0002234168,0.0004255624,0.0003808987,0.0001635338,0.0003818594,0.0002429985,0.0003942329,0.001422066],"category_scores_gemma":[0.001665895,0.000103615,0.0003668883,0.0004789341,0.0001342361,0.0003800443,0.0002346706,0.000767815,0.0001971482],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001657375,"about_ca_system_score_gemma":0.000199219,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005720971,"about_ca_topic_score_gemma":0.00126679,"domain_scores_codex":[0.9996697,0.00008573473,0.00005394983,0.00005015248,0.00008498855,0.00005550907],"domain_scores_gemma":[0.9984295,0.0004043992,0.0007253514,0.00003801026,0.0001442012,0.0002585131],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007862792,0.00009428532,0.9956731,0.00002703853,0.00006078949,0.00004867864,0.00001634755,0.00005859743,0.0003402622,0.000006136477,0.00008209716,0.002806303],"study_design_scores_gemma":[0.00003620766,0.000863032,0.9978597,0.00002210724,0.00008781799,0.0002900116,0.00004526389,0.0003157523,0.0001773937,0.00001164601,0.0002878834,0.000003175221],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9956926,0.00309874,0.0001284463,0.0001086898,0.00001493458,0.00002970271,0.0003913687,0.00000514399,0.000530407],"genre_scores_gemma":[0.9984972,0.0005707854,0.0002110289,0.00004351333,0.00002894353,0.00001736533,0.0004853619,0.000001451294,0.0001442983],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.001422066,"threshold_uncertainty_score":0.004757345,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6927326088","doi":"10.25934/00006041","title":"Histologic Predictors of Endoscopic Healing in Crohn's Disease","year":2023,"lang":"en","type":"dataset","venue":"Vivli","topic":"Bacillus and Francisella bacterial research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Disease; Endoscopy; Abdominal pain; Clinical trial; Inflammatory bowel disease; Ustekinumab; Crohn's disease; Gastrointestinal tract","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01900565370305356,"gpt":0.2862654836652848,"spread":0.2672598299622312,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001799242,0.0003467965,0.0005234341,0.0008948122,0.000215887,0.0006343346,0.0003619123,0.0004938283,0.002313747],"category_scores_gemma":[0.005449536,0.0001438649,0.0003893425,0.001342384,0.0003400891,0.0005034529,0.0004612254,0.001175054,0.000329298],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002083903,"about_ca_system_score_gemma":0.0002252232,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008940333,"about_ca_topic_score_gemma":0.001508612,"domain_scores_codex":[0.9994886,0.0001769106,0.00007132552,0.00006070175,0.0001438618,0.00005863486],"domain_scores_gemma":[0.9956571,0.00121411,0.002003303,0.0001435088,0.0004433104,0.0005387308],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0006061117,0.00005740896,0.9886496,0.0001278334,0.00009548966,0.0000939388,0.00002485155,0.00008174265,0.0002547914,0.00004014217,0.0002585743,0.009709425],"study_design_scores_gemma":[0.00002793739,0.0003449496,0.9967852,0.00009444897,0.0001454863,0.0005743814,0.0001214522,0.0004254227,0.0001572911,0.0001098718,0.001206878,0.000006750553],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9373055,0.05651439,0.0008274605,0.000632387,0.0001779239,0.00004837541,0.000778867,0.00002555921,0.003689596],"genre_scores_gemma":[0.9923494,0.005458891,0.0006670408,0.00009998585,0.0001986117,0.00001520763,0.0007672768,0.000007490498,0.0004360143],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.002313747,"threshold_uncertainty_score":0.009515405,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6945877751","doi":"10.25934/00005318","title":"Randomized, Open Label, 2-way Crossover, Single Dose Bioequivalence Study of Paroxetine IR Tablets Manufactured in GSKT and Mississauga Sites in Healthy Chinese Participants Under Fasting and Fed Conditions","year":2020,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Paroxetine; Bioequivalence; Crossover study; Open label; Anxiety; Randomized controlled trial","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1249546160362639,"gpt":0.3963189462446826,"spread":0.2713643302084187,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007161852,0.001481373,0.00285312,0.0005197147,0.0005662218,0.0009467157,0.00299839,0.001923262,0.02589354],"category_scores_gemma":[0.009041937,0.0005386026,0.001673971,0.00114468,0.0006300551,0.0006067531,0.0009423546,0.001382154,0.00677539],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001754175,"about_ca_system_score_gemma":0.003442999,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008630973,"about_ca_topic_score_gemma":0.01476097,"domain_scores_codex":[0.9974594,0.001315951,0.0002738772,0.0004539261,0.000350654,0.0001462769],"domain_scores_gemma":[0.9960886,0.001021295,0.0009552545,0.0009084312,0.0007035684,0.0003228151],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3037138,0.009278893,0.02353111,0.01113939,0.00546595,0.0003558364,0.0002328817,0.003529378,0.003274068,0.002461963,0.5806168,0.05639983],"study_design_scores_gemma":[0.4218707,0.02139804,0.1515866,0.002156576,0.009745909,0.0007567093,0.0002568671,0.01482388,0.003732601,0.003282746,0.3698711,0.0005183248],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.05755319,0.001305082,0.002450999,0.001047777,0.0002155044,0.01005144,0.9217691,0.0007050137,0.004901876],"genre_scores_gemma":[0.1009785,0.0008310542,0.008992787,0.00161523,0.00009762722,0.03273913,0.8455866,0.000136158,0.009022918],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.02589354,"threshold_uncertainty_score":0.08662254,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7084763686","doi":"10.25934/pr00008615","title":"Using artificial intelligence to predict and prevent physical activity induced hypoglycemia and hyperglycemia in type 1 diabetes","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"Forensic Anthropology and Bioarchaeology Studies","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"","keywords":"Type 1 diabetes; Physical activity; Hypoglycemia; Diabetes mellitus; Continuous glucose monitoring; Artificial pancreas","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.07355117522205301,"gpt":0.3267047640125847,"spread":0.2531535887905317,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001134002,0.001972921,0.001000759,0.002002682,0.0005730243,0.001171597,0.002357828,0.00207252,0.01147616],"category_scores_gemma":[0.004571542,0.0004056107,0.00164692,0.001926603,0.0003216953,0.000514479,0.001086923,0.001282537,0.01047428],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001353341,"about_ca_system_score_gemma":0.00157312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.06280421,"about_ca_topic_score_gemma":0.1227176,"domain_scores_codex":[0.9993388,0.000146492,0.00008324645,0.0001868432,0.0001477152,0.00009679623],"domain_scores_gemma":[0.9986446,0.0004723705,0.000134536,0.0002465388,0.0003557306,0.0001461633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0005186087,0.0003131952,0.02039349,0.001102597,0.0002396268,0.0001360809,0.00004450801,0.003517705,0.000314676,0.0003943428,0.9579978,0.0150273],"study_design_scores_gemma":[0.002498543,0.0005469799,0.1371127,0.002063332,0.0008595958,0.0007069983,0.00081694,0.03761237,0.003024977,0.004358975,0.8101364,0.000262326],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.005971719,0.0003499122,0.0002502393,0.0004010861,0.0001423954,0.00006334793,0.9911851,0.00038517,0.001250952],"genre_scores_gemma":[0.005637697,0.0001089592,0.0008584775,0.0001095226,0.00001766058,0.0001119924,0.9923584,0.00001684176,0.0007804452],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.06280421,"threshold_uncertainty_score":0.1248773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6908464859","doi":"10.25934/00005706","title":"A Phase III, Open-Label, Single-Arm Study of Tenecteplase for Restoration of Function in Dysfunctional Central Venous Catheters","year":2020,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Tenecteplase; Dysfunctional family; Phase (matter); Function (biology); Central venous catheter","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.08591047963763426,"gpt":0.3287628417882431,"spread":0.2428523621506088,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002743607,0.001427928,0.002033105,0.000356667,0.0004307613,0.001024317,0.001513322,0.001190615,0.007515403],"category_scores_gemma":[0.002302858,0.0004605844,0.001252998,0.0006226045,0.0004496278,0.0005200779,0.0004059867,0.002053419,0.001856405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001581729,"about_ca_system_score_gemma":0.004921959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005991525,"about_ca_topic_score_gemma":0.0177928,"domain_scores_codex":[0.9994153,0.000302905,0.00002596654,0.00008293647,0.00008573646,0.00008709848],"domain_scores_gemma":[0.9988959,0.0002462983,0.0002520122,0.0001218369,0.0001738593,0.0003101006],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.5742021,0.02840185,0.01170132,0.005382807,0.004932674,0.0003321368,0.0001563325,0.005567358,0.01021622,0.001437857,0.245943,0.1117264],"study_design_scores_gemma":[0.8685099,0.04242699,0.0206763,0.0005235322,0.002557657,0.0004485266,0.00007714069,0.004320199,0.001715758,0.000994243,0.05764834,0.0001014119],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.4876993,0.01787811,0.005994771,0.004488714,0.001020535,0.02481807,0.434928,0.001156088,0.02201646],"genre_scores_gemma":[0.547147,0.01419903,0.01494451,0.007834118,0.000527643,0.0478405,0.3493249,0.0003385225,0.01784382],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.007515403,"threshold_uncertainty_score":0.02514154,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7115935029","doi":"10.25934/pr00012083.0","title":"Available datapackage for study 'Effect and Safety of Semaglutide 2.4 mg Once-weekly in Subjects With Overweight or Obesity'","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Semaglutide; Overweight; Weight loss; Body weight; Alternative medicine; Phone call","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01524119746711726,"gpt":0.2793060397677061,"spread":0.2640648423005888,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003266997,0.001755994,0.002094893,0.002100133,0.0005948466,0.001889221,0.002168189,0.002712473,0.1868044],"category_scores_gemma":[0.02032086,0.0008904163,0.002639394,0.004052211,0.0002862124,0.001083222,0.001616586,0.001690979,0.06577089],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001349627,"about_ca_system_score_gemma":0.002998975,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01799764,"about_ca_topic_score_gemma":0.03054504,"domain_scores_codex":[0.9981134,0.000476984,0.0004355677,0.0003970387,0.0003648621,0.0002122417],"domain_scores_gemma":[0.9888469,0.005771573,0.001834871,0.001288815,0.001685995,0.0005717829],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001195103,0.00008307929,0.002982313,0.006085346,0.0003758672,0.00003275395,0.00003147278,0.0003585739,0.0002472496,0.0004735458,0.9812231,0.006911576],"study_design_scores_gemma":[0.006919216,0.0002816884,0.02188188,0.003125622,0.0008089236,0.0001441622,0.00006222112,0.0007348677,0.000610105,0.001727126,0.963617,0.00008719479],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"dataset","genre_gemma":"dataset","genre_scores_codex":[0.0001032128,0.0001143037,0.00006360011,0.00006591768,0.00001873485,0.00002988734,0.9991192,0.0001170915,0.0003680529],"genre_scores_gemma":[0.001124795,0.0002445242,0.0005218946,0.0002804537,0.0000196507,0.0004854527,0.9960949,0.0001404068,0.001087937],"genre_candidate":"dataset","genre_consensus":"dataset","teacher_disagreement_score":0.1868044,"threshold_uncertainty_score":0.6249229,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W7106120572","doi":"10.25934/pr00011790","title":"An analysis of outcome measures for the design of phase 2 futility trials in Alzheimer's Disease (AD)","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Calgary","funders":"","keywords":"Disease; Clinical trial; Dementia; Outcome (game theory); Research design; Test (biology); Placebo; Randomized controlled trial","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.2650097424569893,"gpt":0.4638805644370095,"spread":0.1988708219800202,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3413874,0.005044009,0.01060052,0.005051785,0.001738729,0.003611542,0.003279147,0.006634588,0.01644958],"category_scores_gemma":[0.4410928,0.001890826,0.0182137,0.003678259,0.003855666,0.004463248,0.003623019,0.007984274,0.002054177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.004389322,"about_ca_system_score_gemma":0.006190611,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007013836,"about_ca_topic_score_gemma":0.0006464026,"domain_scores_codex":[0.5083264,0.4381548,0.01773722,0.01315021,0.01904856,0.003582831],"domain_scores_gemma":[0.504775,0.423923,0.02869425,0.02654742,0.01370698,0.002353332],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.3550139,0.006202383,0.0168565,0.01890023,0.0480895,0.0005522143,0.001888991,0.03370331,0.004981334,0.08526418,0.02491904,0.4036284],"study_design_scores_gemma":[0.1811532,0.1833581,0.02906357,0.005900455,0.04398269,0.0006637161,0.0006370411,0.297375,0.009846734,0.1595426,0.0873966,0.001080193],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"methods","genre_gemma":"dataset","genre_scores_codex":[0.06317436,0.007797712,0.7498952,0.004670046,0.007050022,0.1528192,0.004424615,0.0022022,0.00796662],"genre_scores_gemma":[0.2175649,0.001071861,0.416755,0.002531967,0.0006135925,0.3563735,0.001742683,0.0003644006,0.002982054],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.3413874,"threshold_uncertainty_score":0.8121866,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6964833193","doi":"10.25934/00000270","title":"A Multi-Center, Randomized, Phase 3 Study of Rituximab Versus Iodine I 131 Tositumomab Therapeutic Regimen For Patients With Relapsed Follicular Non-Hodgkins Lymphoma","year":2018,"lang":"en","type":"dataset","venue":"Vivli","topic":"Ecology and biodiversity studies","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Radioimmunotherapy; Regimen; Rituximab; Thyroid; Therapeutic index; Follicular phase; Iodine","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01739197578186702,"gpt":0.2618079921059929,"spread":0.2444160163241259,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00298595,0.001866822,0.003680115,0.000507821,0.0006975749,0.001333263,0.001277553,0.002004972,0.004052577],"category_scores_gemma":[0.001942847,0.0009386584,0.002262501,0.0004904767,0.001273828,0.001117495,0.0004065159,0.003428532,0.0009355507],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001104655,"about_ca_system_score_gemma":0.001718394,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001226642,"about_ca_topic_score_gemma":0.0029682,"domain_scores_codex":[0.9987732,0.0007322792,0.00006905458,0.0001756301,0.00008184635,0.0001680261],"domain_scores_gemma":[0.9984536,0.0004277598,0.000257153,0.0001346489,0.000112644,0.0006142511],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9739402,0.01415076,0.0005541217,0.0001798613,0.0005483098,0.00003275818,0.0000513337,0.0002147122,0.002255803,0.00004473385,0.0003678869,0.007659577],"study_design_scores_gemma":[0.8726544,0.1246675,0.001666241,0.000009282427,0.0002160162,0.00001637219,0.00001461921,0.0002722127,0.000179365,0.00006048206,0.0002321466,0.0000113484],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9910703,0.00199626,0.0005009363,0.0004359228,0.0004080734,0.003939598,0.0004350525,0.0001008437,0.001113022],"genre_scores_gemma":[0.9883347,0.001230639,0.001378539,0.001357089,0.0005249262,0.004832261,0.0006961731,0.00002404412,0.001621722],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.004052577,"threshold_uncertainty_score":0.01579142,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W6946015985","doi":"10.25934/pr00008602","title":"Statin use and prostate cancer outcomes in patients treated in the ARAMIS trial","year":2025,"lang":"en","type":"dataset","venue":"Vivli","topic":"","field":"","cited_by":0,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Prostate cancer; Statin; Concomitant; Disease; Cancer; Testosterone (patch); Prostate","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.02671447283291692,"gpt":0.320700576742342,"spread":0.293986103909425,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008769889,0.000204373,0.000819353,0.0002415845,0.0002943857,0.0008791618,0.0002781471,0.0009081051,0.002143941],"category_scores_gemma":[0.00238865,0.0001876438,0.001455227,0.000578961,0.0001869759,0.0005471337,0.0003447653,0.001561079,0.0003117836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004352823,"about_ca_system_score_gemma":0.0006394193,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0024281,"about_ca_topic_score_gemma":0.005371126,"domain_scores_codex":[0.9993646,0.0002636464,0.00008804166,0.00008747538,0.00009174583,0.0001045136],"domain_scores_gemma":[0.9992975,0.0001109257,0.0002543469,0.00005269066,0.00007577599,0.0002087351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","study_design_scores_codex":[0.4245752,0.004248047,0.3641785,0.00657628,0.01788956,0.0003413573,0.0003408108,0.001858216,0.003097546,0.001970605,0.02364589,0.1512781],"study_design_scores_gemma":[0.08283594,0.02784695,0.8418569,0.002214518,0.01805741,0.000543243,0.000399245,0.002977354,0.00104188,0.003054294,0.01897234,0.0002000309],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"dataset","genre_scores_codex":[0.9207219,0.06019258,0.0002035766,0.003775731,0.000630143,0.000244209,0.003924142,0.00005315557,0.01025465],"genre_scores_gemma":[0.9883718,0.006376269,0.0001315515,0.001143802,0.0002726978,0.0001143674,0.002291963,0.000006297964,0.001291321],"genre_candidate":"dataset","genre_consensus":null,"teacher_disagreement_score":0.0024281,"threshold_uncertainty_score":0.007172227,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}